Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
Cancer Cell, ISSN: 1535-6108, Vol: 21, Issue: 1, Page: 52-65
2012
- 140Citations
- 212Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations140
- Citation Indexes140
- 140
- CrossRef101
- Captures212
- Readers212
- 206
Article Description
The hypoxia inducible transcription factors (HIFs) control many mediators of vascular response, including both angiogenic factors and small molecules such as nitric oxide (NO). In studying how endothelial HIF response itself affects metastasis, we found that loss of HIF-1α in endothelial cells reduces NO synthesis, retards tumor cell migration through endothelial layers, and restricts tumor cell metastasis, and that loss of HIF-2α has in each case the opposite effect. This results from differential regulation of NO homeostasis that in turn regulates vascular endothelial growth factor expression in an NO-dependent feedback loop. These opposing roles for the two HIF factors indicate that both they and endothelial cells regulate metastasis as malignancy progresses.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1535610811004405; http://dx.doi.org/10.1016/j.ccr.2011.11.017; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84862909156&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/22264788; https://linkinghub.elsevier.com/retrieve/pii/S1535610811004405; http://www.cell.com/cancer-cell/abstract/S1535-6108(11)00440-5; http://linkinghub.elsevier.com/retrieve/pii/S1535610811004405; https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=http%3A%2F%2Fwww.cell.com%2Fcancer-cell%2Fabstract%2FS1535-6108%2811%2900440-5&rc=0&code=cell-site; http://acw.elsevier.com/SSOCore?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.cell.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253DaaaiwrpM7yw7UekYj33xv%2526MAID%253DGWk0PMaQLvIfCK6lOUjbrw%25253D%25253D%2526SERVER%253DWZ6myaEXBLFhx%25252B6Ws3Nrug%25253D%25253D%2526ORIGIN%253D442515031%2526RD%253DRD; http://acw.elsevier.com/SSOCore/?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.cell.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253DaaaiwrpM7yw7UekYj33xv%2526MAID%253DGWk0PMaQLvIfCK6lOUjbrw%25253D%25253D%2526SERVER%253DWZ6myaEXBLFhx%25252B6Ws3Nrug%25253D%25253D%2526ORIGIN%253D442515031%2526RD%253DRD; https://secure.jbs.elsevierhealth.com/action/consumeSsoCookie?redirectUri=http%3A%2F%2Fwww.cell.com%2Faction%2FconsumeSharedSessionAction%3FJSESSIONID%3DaaaiwrpM7yw7UekYj33xv%26MAID%3DGWk0PMaQLvIfCK6lOUjbrw%253D%253D%26SERVER%3DWZ6myaEXBLFhx%252B6Ws3Nrug%253D%253D%26ORIGIN%3D442515031%26RD%3DRD&acw=&utt=
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know